Please do not adjust margins
Organic & Biomolecular Chemistry
Page 4 of 5
COMMUNICATION
Journal Name
6
7
Based on our results, a plausible mechanism for the I2–TBHP-
catalyzed regiocontrolled cycloaddition was proposed as
shown in Scheme 3. Iodine acts as a strong Lewis acid to
coordinate with the nitrogen atom of the N-tosyl
(b) J. J. Li, J. J. Li, J. Li, A. K. Trehan, H. SD. OWI:o1n0g.1,0S3.9/C6OB01926A
Krishnananthan, L. J. Kennedy, Q. Gao, A. Ng, J. A. Robl, B.
Balasubramanian and B.-C. Chen, Org. Lett., 2008, 10, 2897;
(c) J. Y. Roberge, G. Pei, M. Mikkilineni, X. Wu, Y. Zhu, R. M.
aldohydrazone
dipolar complex
intermolecular formal [3+2]-cycloaddition between the dipolar
complex and dipolarophile ended up with fused
cycloadduct followed by reductive elimination of HI to
generate the fused triazoline intermediate . The eliminated HI
was oxidized to I2 in the presence of TBHP and the catalytic
cycle was regenerated.16 Finally loss of TsH from
afforded the
fused triazole product
A
leading to the formation of azomethine imine
Lawrence and W. R. Ewing, ARKIVOC, 2007, 7, 132 and
references cited therein; (d) E. C. Lawson, B. E. Maryanoff
and W. J. Hoekstra, Tetrahedron Lett., 2000, 41, 4533.
(a) E. S. H. El Ashry and M. M. Abdul-Ghani, Nucleosides,
Nucleotides Nucleic Acids, 2004, 23, 567; (b) M. Ciesielski, D.
Pufky and M. Döring, Tetrahedron, 2005, 61, 5942; (c) K.
Ĉuček and B. Verček, Synlett, 1994, 1994, 667; (d) V. S.
Padalkar, V. S. Patil, K. R. Phatangare, P. G. Umape and N.
Sekar, Synth. Commun., 2011, 41, 925.
B
by elimination of HI. Then the unidirectional
B
C
D
E
E
8
9
K. D. Baucom, S. C. Jones and S. W. Roberts, Org. Lett., 2016,
18, 560.
A. Moulin, J. Martinez and J.-A. Fehrentz, Tetrahedron Lett.,
2006, 47, 7591.
F
.
In summary, we have developed a highly efficient one-pot
methodology to synthesize structurally diverse 4,3-fused 1,2,4-
triazole derivatives using the catalytic system comprising of I2–
TBHP. The reactions proceeded under mild and metal-free
conditions using readily available starting substrates and gave
high yields, regioselectivity and wide functional group
tolerance which clearly demonstrates the unparalleled and
unique reactivity of the I2–TBHP system.
10 D. K. Maiti, N. Chatterjee, P. Pandit and S. K. Hota, Chem.
Commun., 2010, 46, 2022.
11 (a) P. Finkbeiner and B. J. Nachtsheim, Synthesis, 2013, 45
,
979; (b) Y.-M. Ren, C. Cai and R.-C. Yang, RSC Adv., 2013, 3,
7182; (c) P. T. Parvatkar, P. S. Parameswaran and S. G. Tilve,
Chem. Eur. J., 2012, 18, 5460; (d) M. Jereb, D. Vražič and M.
–
Zupan, Tetrahedron, 2011, 67, 1355; (e) M. J. Mphahlele,
Molecules, 2009, 14, 5308; (f) A. K. Banerjee, W. Vera, H.
Mora, M. S. Laya, L. Bedoya and E. V. Cabrera, J. Sci. Ind.
Res., 2006, 65, 299; (g) H. Togo and S. Iida, Synlett, 2006, 14
Authors sincerely thank the Senior Management of Jubilant
Biosys Ltd. for providing the facilities to conduct this research
work.
,
2159; (h) P. Gogoi and D. Konwar, Org. Biomol. Chem., 2005,
, 3473.
12 (a) Z. H. He, H. R. Li and Z. P. Li, J. Org. Chem., 2010, 75
3
,
4636; (b) F.-L. Yang and S.-K. Tian, Angew. Chem., Int. Ed.,
2013, 52, 4929; (c) Q. Gao, S. Liu, X. Wu and A. Wu, Org.
Lett., 2014, 16, 4582; (d) Y. Yan, Y. Zhang, C. Feng, Z. Zha and
Z. Wang, Angew. Chem., Int. Ed., 2012, 51, 8077.
13 S. B. Inturi, B. Kalita and A. J. Ahamed, Tetrahedron Lett.,
2016, 57, 2227.
14 For the details on the reaction condition optimization, see
the ESI†.
15 The X-ray crystallographic structures for 3h and 6k have been
deposited at the Cambridge Crystallographic Data Centre
(CCDC), under deposition numbers CCDC 1487670 and
1487669, respectively.
Notes and references
1
(a) R. W. Carling, K. W. Moore, L. J. Street, D. Wild, C. Isted,
P. D. Leeson, S. Thomas, D. O’Connor, R. M. McKernan, K.
Quirk, S. M. Cook, J. R. Atack, K. A. Wafford, S. A. Thompson,
G. R. Dawson, P. Ferris and J. L. Castro, J. Med. Chem., 2004,
47, 1807; (b) L.-J. Guo, C.-X. Wei, J.-H. Jia, L.-M. Zhao and Z.-
S. Quan, Eur. J. Med. Chem., 2009, 44, 954; (c) A. K. Sadana,
Y. Mirza, K. R. Aneja and O. Prakash, Eur. J. Med. Chem.,
2003, 38, 533; (d) Y. Yoshimura, K. Tomimatsu, T. Nishimura,
A. Miyake and N. Hashimoto, J. Antibiot., 1992, 45, 721.
(a) G. C. Senadi, W.-P. Hu, T.-Y. Lu, A. M. Garkhedkar, J. K.
Vandavasi and J.-J. Wang, Org. Lett., 2015, 17, 1521; (b) T.
Nobuta, N. Tada, A. Fujiya, A. Kariya, T. Miura and A. Itoh,
Org. Lett., 2013, 15, 574; (c) J. Zhang, D. Zhu, C. Yu, C. Wan
and Z. Wang, Org. Lett., 2010, 12, 2841; (d) Y. Yan, Y. Zhang,
Z. Zha and Z. Wang, Org. Lett., 2013, 15, 2274; (e) S. Tang, K.
2
16 Z.-J. Cai, X.-M. Lu, Y. Zi, C. Yang, L.-J. Shen, J. Li, S.-Y. Wang
and S.-J. Ji, Org. Lett., 2014, 16, 5108.
Liu, Y. Long, X. Gao, M. Gao and A. Lei, Org. Lett., 2015, 17
2404; (f) S. Tang, K. Liu, Y. Long, X. Qi, Y. Lan and A. Lei,
,
Chem. Commun., 2015, 51, 8769; (g) T.-H. Zhu, T.-Q. Wei, S.-
Y. Wang and S.-J. Ji, Org. Chem. Front., 2015, , 259; (h) Y.
2
Yan and Z. Wang, Chem. Commun., 2011, 47, 9513.
(a) E. C. Lawson, W. J. Hoekstra, M. F. Addo, P. Andrade-
Gordon, B. P. Damiano, J. A. Kauffman, J. A. Mitchell and B. E.
Maryanoff, Bioorg. Med. Chem. Lett., 2001, 11, 2619; (b) D.
Kim, L. Wang, J. J. Hale, C. L. Lynch, R. J. Budhu, M. MacCoss,
S. G. Mills, L. Malkowitz, S. L. Gould, J. A. DeMartino, M. S.
Springer, D. Hazuda, M. Miller, J. Kessler, R. C. Hrin, G.
Carver, A. Carella, K. Henry, J. Lineberger, W. A. Schleif and E.
A. Emini, Bioorg. Med. Chem. Lett., 2005, 15, 2129; (c) N.
Shao, R. Aslanian, R. E. West, S. M. Williams, R.-L. Wu, J.
Hwa, C. Sondey, J. Lachowicz and A. Palani, Bioorg. Med.
Chem. Lett., 2012, 22, 2075.
3
4
5
A. Reichelt, J. R. Falsey, R. M. Rzasa, O. R. Thiel, M. M.
Achmatowicz, R. D. Larsen and D. Zhang, Org. Lett., 2010, 12
,
792.
O. R. Thiel, M. M. Achmatowicz, A. Reichelt and R. D. Larsen,
Angew. Chem., Int. Ed., 2010, 49, 8395.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins